CAR T-cell therapy
Are there promising treatment options for multiple myeloma on the horizon?
Irene Ghobrial • 10 Dec 2017
Responses to CAR T-Cell therapy still strong after one year in patients with refractory NHL
Six-month analysis of tisagenlecleucel in stubborn form of lymphoma shows sustained responses
What are the challenges of integrating therapy around autologous transplantation?
John Kuruvilla • 8 Sep 2017
iwNHL 2015 roundtable: Day 2 highlights – CAR T-cell therapy for non-Hodgkin lymphoma
John Gribben et al. • 3 Oct 2015